Abstract

Hepatitis C (HCV) is a major cause of liver disease, in which a third of individuals with chronic HCV infections may develop liver cirrhosis. In a chronic HCV infection, host immune factors along with the actions of HCV proteins that promote viral persistence and dysregulation of the immune system have an impact on immunopathogenesis of HCV-induced hepatitis. The genome of HCV encodes a single polyprotein, which is translated and processed into structural and nonstructural proteins. These HCV proteins are the target of the innate and adaptive immune system of the host. Retinoic acid-inducible gene-I (RIG-I)-like receptors and Toll-like receptors are the main pattern recognition receptors that recognize HCV pathogen-associated molecular patterns. This interaction results in a downstream cascade that generates antiviral cytokines including interferons. The cytolysis of HCV-infected hepatocytes is mediated by perforin and granzyme B secreted by cytotoxic T lymphocyte (CTL) and natural killer (NK) cells, whereas noncytolytic HCV clearance is mediated by interferon gamma (IFN-γ) secreted by CTL and NK cells. A host–HCV interaction determines whether the acute phase of an HCV infection will undergo complete resolution or progress to the development of viral persistence with a consequential progression to chronic HCV infection. Furthermore, these host–HCV interactions could pose a challenge to developing an HCV vaccine. This review will focus on the role of the innate and adaptive immunity in HCV infection, the failure of the immune response to clear an HCV infection, and the factors that promote viral persistence.

Highlights

  • The liver is the metabolism hub of the body, which is responsible for all major anabolic and catabolic activities for survival

  • dendritic cell (DC) play an important role in initiating adaptive immune response to virus; a reduced frequency of mDCs and plasmacytoid DC (pDC) is observed during an HCV infection [118,120], and this can be correlated with an impaired capacity of these cells to activate T cells [118]

  • Host and viral factors play a role in host–viral interactions that could result in a spontaneous resolution of the acute infection or a progression to a chronic HCV infection

Read more

Summary

Introduction

The liver is the metabolism hub of the body, which is responsible for all major anabolic and catabolic activities for survival. For HCV, around $300 million is spent on liver transplant every year and the economic burden for infected patient healthcare costs approaches $9 billion [10] All these reasons make up a powerful stimulus to study and eradicate these viruses. This review focuses on the interactions of HCV with the host immune system and the mechanisms responsible for the development of viral persistence and subsequent progression to a chronic HCV infection. The result of a study of HCV-genotype-1-infected individuals showed that polymorphisms of the IL28B (IFN-λ3) gene is protective against chronic Hepatitis C and a predictor of response to interferon-based therapy [27]. Stimulation of Drp by HCV is a major factor in HCV virulence, which leads to an uneven fragmentation of mitochondria [23]

Clinical Manifestations
HCV and Host Interaction
HCV replication including and entry into the host
Innate Immune Response in HCV Infection
Adaptive Immune Response in HCV Infection
Effect of HCV on Myeloid Cells
Effect of HCV on Lymphoid Cells
Effect of HCV on Nonimmune Cells
Mechanisms Responsible for the Development of Chronic HCV Infection
Impact of Host–HCV Interactions on HCV Therapy
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call